Purchase Order 75D30123P16985
Award Date 6/27/23
Potential Completion Date 7/11/23
Potential Value $250K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to 10X Genomics, Inc., a life sciences technology company, by the Centers for Disease Control and Prevention (CDC). The $75,072 firm fixed-price contract is for the provision of goods and services related to 10X Genomics' genomic analysis platforms, reagents, instruments, and bioinformatics software. These products and services support single-cell and spatial analysis applications, enabling high-throughput interrogation of biological systems at the single-cell...
- This contract awards 10X Genomics, Inc., a purchase order for the company's Chromium Connect System for single cell workflow, which was a sole source procurement by the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services. The $249,950.00 firm fixed price contract provides laboratory equipment, with no set-aside used. 10X Genomics is a for-profit life sciences technology company that supplies a range of genomic analysis platforms, reagents,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to 10X Genomics, Inc., doing business as 10X Genomics, for $102,601.16. 10X Genomics is a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The contract is for the delivery of laboratory equipment, with no set-aside used. 10X Genomics has previously provided specialized kits,...
- This is a federal contract awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention to 10X Genomics, Inc. for the provision of lab supplies valued at $162,392.88. The contract is a firm fixed price purchase order with a completion date of October 18, 2022. 10X Genomics, Inc. is a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The contract does not have a set-aside designation....
- 10X Genomics, Inc., a life sciences technology company, was awarded a Firm Fixed Price Purchase Order contract by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) for the annual maintenance of a Chromium IX Unit. The contract, which does not have a set-aside designation, has a potential value of $60,000.00 and a completion date of September 29, 2027. 10X Genomics, as the prime contractor, will provide the necessary goods and services to...
- The federal contract award with ID 75D30122P13807 was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility, a civilian agency, to 10X Genomics, Inc., a for-profit manufacturer of life sciences technology products and services. The $95,000.00 firm fixed price purchase order is for the delivery of the company's "CHROMIUM X" products and services, which include specialized kits, instruments, and associated services for single-cell and spatial analysis...
- The Department of Health and Human Services' Centers for Disease Control and Prevention awarded a firm fixed price contract to 10X Genomics, Inc. for "CHROMIUM SINGLE CELL" products and services. The $134,995.00 contract does not have a set-aside designation. 10X Genomics, a life sciences technology company, provides genomic analysis platforms, reagents, instruments, and bioinformatics software to enable high-throughput interrogation of biological systems at single cell resolution....
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to 10X Genomics, Inc., a for-profit manufacturer of life sciences products and services. The contract is valued at $112,686.00 and is set aside for small businesses. It is for the provision of single cell RNA library and sequencing reagent kits in support of the National Interest Action related to the Coronavirus...
- <p>The CDC Pittsburgh awarded a purchase order to 10X Genomics, Inc. valued at $104,850 on May 30, 2023, for 10X Genomics immunology products on a firm fixed price basis. The order is not set-aside. Performance occurs in Atlanta, Georgia, with completion due June 12, 2027.</p>
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to 10X Genomics, Inc., a small business manufacturer of life sciences products and services. The $113,620.00 contract provides Chromium Libraries, which are specialized genomics kits and associated instruments for single-cell and spatial analysis applications. This contract supports the National...
10X Genomics, Inc., doing business as 10X Genomics, has been awarded a firm fixed price purchase order valued at $249,649.15 by the Centers for Disease Control and Prevention (CDC) to provide single-cell RNA-seq library preparation services. The purpose of this contract is to support CDC's efforts to study the host immune response induced by influenza vaccines through transcriptomic analysis at the single-cell level. Performance will take place in Atlanta, Georgia over a two week period concluding in mid-July 2023. No subcontractors or set aside designations were identified. This award furthers CDC's infectious disease programs through advanced genomic technologies.
Generated 12/15/23, 11:08 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $249.6k | 6/27/23 |